Radiological Quantification of Sarcopenic Obesity and its Role in Chronic Liver Disease Severity.

[1]  Wanting Yang,et al.  Sarcopenic obesity in liver disease: Handling both sides of the penny , 2022, Portal Hypertension & Cirrhosis.

[2]  Chiung-Yu Huang,et al.  Sarcopenic visceral obesity is associated with increased post‐liver transplant mortality in acutely ill patients with cirrhosis , 2022, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[3]  Thomas Maurel,et al.  Impact of Sarcopenia on the Severity of the Liver Damage in Patients With Non-alcoholic Fatty Liver Disease , 2022, Frontiers in Nutrition.

[4]  C. Hsiung,et al.  Longitudinal changes in physical and mental health of older adults with chronic hepatitis B infection: Trajectories and predictors , 2021, Preventive medicine reports.

[5]  H. Iijima,et al.  Sarcopenic Obesity in Liver Cirrhosis: Possible Mechanism and Clinical Impact , 2021, International journal of molecular sciences.

[6]  M. Nguyen,et al.  Sarcopenic Obesity in Non-Alcoholic Fatty Liver Disease—The Union of Two Culprits , 2021, Life.

[7]  Mimi Kim,et al.  Radiologic Definition of Sarcopenia in Chronic Liver Disease , 2021, Life.

[8]  A. Sanyal,et al.  Harnessing Muscle–Liver Crosstalk to Treat Nonalcoholic Steatohepatitis , 2020, Frontiers in Endocrinology.

[9]  A. Ba-Ssalamah,et al.  MRI‐defined sarcopenia predicts mortality in patients with chronic liver disease , 2020, Liver international : official journal of the International Association for the Study of the Liver.

[10]  Bangmao Wang,et al.  Low psoas muscle index associates with long-term mortality in cirrhosis: construction of a nomogram , 2020, Annals of translational medicine.

[11]  Ronald M. Summers,et al.  A Machine Learning Algorithm to Estimate Sarcopenia on Abdominal CT. , 2020, Academic radiology.

[12]  A. Montano‐Loza,et al.  A North American Expert Opinion Statement on Sarcopenia in Liver Transplantation , 2019, Hepatology.

[13]  R. Bhargava,et al.  Sarcopenia in Chronic Liver Disease: Impact on Outcomes , 2019, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[14]  Joey Nicholson,et al.  Automated Segmentation of Tissues Using CT and MRI: A Systematic Review. , 2019, Academic radiology.

[15]  Nabile M. Safdar,et al.  MRI Quantitation of Abdominal Skeletal Muscle Correlates with CT-Based Analysis: Implications for Sarcopenia Measurement. , 2019, Applied physiology, nutrition, and metabolism = Physiologie appliquee, nutrition et metabolisme.

[16]  S. Yagi,et al.  Impact of Sarcopenic Obesity on Outcomes in Patients Undergoing Hepatectomy for Hepatocellular Carcinoma , 2017, Annals of surgery.

[17]  A. Montano‐Loza,et al.  Sarcopenic obesity in cirrhosis—The confluence of 2 prognostic titans , 2018, Liver international : official journal of the International Association for the Study of the Liver.

[18]  Sunita Kumari,et al.  Has the time come for using MELD-Sarcopenia score? , 2018, Journal of hepatology.

[19]  M. Correia,et al.  Association between pre‐sarcopenia, sarcopenia, and bone mineral density in patients with chronic hepatitis C , 2018, Journal of cachexia, sarcopenia and muscle.

[20]  J. Ijzermans,et al.  A model including sarcopenia surpasses the MELD score in predicting waiting list mortality in cirrhotic liver transplant candidates: A competing risk analysis in a national cohort. , 2017, Journal of hepatology.

[21]  A. Gossum,et al.  ESPEN guidelines on definitions and terminology of clinical nutrition. , 2017, Clinical nutrition.

[22]  G. Baffy,et al.  Obesity paradox in advanced liver disease: obesity is associated with lower mortality in hospitalized patients with cirrhosis , 2016, Liver international : official journal of the International Association for the Study of the Liver.

[23]  K. Esser,et al.  Nonalcoholic steatohepatitis is strongly associated with sarcopenic obesity in patients with cirrhosis undergoing liver transplant evaluation , 2016, Journal of gastroenterology and hepatology.

[24]  M. Sawyer,et al.  Sarcopenic obesity and myosteatosis are associated with higher mortality in patients with cirrhosis , 2015, Journal of cachexia, sarcopenia and muscle.

[25]  J. Jang,et al.  Sarcopenia in the prognosis of cirrhosis: Going beyond the MELD score. , 2015, World journal of gastroenterology.

[26]  K. Thomopoulos,et al.  Impact of muscle wasting on survival in patients with liver cirrhosis. , 2015, World journal of gastroenterology.

[27]  A. Garber,et al.  Post‐liver transplantation sarcopenia in cirrhosis: A prospective evaluation , 2014, Journal of gastroenterology and hepatology.

[28]  C. Pfirrmann,et al.  Dixon-based MRI for assessment of muscle-fat content in phantoms, healthy volunteers and patients with achillodynia: comparison to visual assessment of calf muscle quality , 2014, European Radiology.

[29]  B. Graubard,et al.  Metabolic syndrome increases the risk of primary liver cancer in the United States: A study in the SEER‐medicare database , 2011, Hepatology.

[30]  C. Nishida,et al.  Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies , 2004, The Lancet.

[31]  R. Wiesner,et al.  The new liver allocation system: Moving toward evidence‐based transplantation policy , 2002, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.